regenerative approach treatment multiple sclerosis
progressive phases multiple sclerosis associated inhibited differentiation progenitor cell population generates mature oligodendrocytes required remyelination disease remission identify selective inducers oligodendrocyte differentiation performed image-based screen myelin basic protein mbp expression using primary rat optic-nerve-derived progenitor cells show among effective compounds identifed benztropine significantly decreases clinical severity experimental autoimmune encephalomyelitis eae model relapsing-remitting multiple sclerosis administered alone combination approved immunosuppressive treatments multiple sclerosis evidence cuprizone-inducedmodel demyelination vitro vivo t-cell assays eae adoptive transfer experiments indicated observed efficacy drug results directly enhancement remyelination rather immune suppression pharmacological studies indicate benztropine functions mechanism involves direct antagonism m1 and/or m3 muscarinic receptors studies facilitate development effective new therapies treatment multiple sclerosis complement established immunosuppressive approaches
